Characterization of a novel oral glucocorticoid system and its possible role in disease

Journal of Dental Research

Volumn 91, Issue 1, 2012, Pages 97-103

  Cirillo, N ^a   Hassona, Y ^a   Pignatelli, M ^b   Gasparoto, T H ^c   Morgan, D J ^a   Prime, S S ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

cortisol; fibroblasts; keratinocytes; oral cancer; oral mucosa; pemphigus vulgaris

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 18ALPHA GLYCYRRHETINIC ACID; 18ALPHA-GLYCYRRHETINIC ACID; ANTIINFLAMMATORY AGENT; CORTICOTROPIN; DRUG DERIVATIVE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLYCYRRHETINIC ACID; HYDROCORTISONE; MELANOCORTIN 2 RECEPTOR;

ACANTHOLYSIS; ADENOSQUAMOUS CARCINOMA; ARTICLE; BIOSYNTHESIS; BLOOD; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; EPITHELIUM CELL; FIBROBLAST; HUMAN; METABOLISM; MOUTH MUCOSA; MOUTH TUMOR; PEMPHIGUS; SALIVARY GLAND; SQUAMOUS CELL CARCINOMA;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ACANTHOLYSIS; ADRENOCORTICOTROPIC HORMONE; ANTI-INFLAMMATORY AGENTS; CARCINOMA, MUCOEPIDERMOID; CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; EPITHELIAL CELLS; FIBROBLASTS; GLUCOCORTICOIDS; GLYCYRRHETINIC ACID; HUMANS; HYDROCORTISONE; MOUTH MUCOSA; MOUTH NEOPLASMS; PEMPHIGUS; RECEPTOR, MELANOCORTIN, TYPE 2; RECEPTORS, GLUCOCORTICOID; SALIVARY GLANDS;

EID: 83455235836     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034511427909     Document Type: Article

References (32)

1. Arredondo J, Chernyavsky AI, Karaouni A, Grando SA. Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in pemphigus. Am J Pathol. 2005 ; 167: 1531-1544 (Pubitemid 41713308)
2. Barnes PJ. Glucocorticosteroids: current and future directions. Br J Pharmacol. 2011 ; 163: 29-43
3. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol. 1988 ; 106: 761-771 (Pubitemid 18089976)
4. Calautti E, Cabodi S, Stein PL, Hatzfeld M, Kedersha N, Paolo Dotto G. Tyrosine phosphorylation and Src-family kinases control keratinocyte cell-cell adhesion. J Cell Biol. 1998 ; 141: 1449-1465 (Pubitemid 28289919)
5. Cirillo N, Prime SS. Keratinocytes synthesize and activate cortisol: first characterisation of a novel epidermal glucocorticoid system. J Cell Biochem. 2011 ; 112: 1499-1505
6. Cirillo N, Femiano F, Gombos F, Lanza A. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes. FEBS Lett. 2006 ; 580: 3276-3281 (Pubitemid 43729682)
7. Cirillo N, Femiano F, Dell'Ermo A, Arnese P, Gombos F, Lanza A. A novel method to investigate pemphigus-induced keratinocyte dysmorphisms through living cell immunofluorescence microscopy. Virchows Arch. 2007 ; 450: 683-690 (Pubitemid 46986225)
8. Cirillo N, Lanza A, Prime SS. Induction of hyper-adhesion attenuates autoimmune-induced keratinocyte cell-cell detachment and processing of adhesion molecules via mechanisms that involve PKC. Exp Cell Res. 2010 ; 316: 580-592
9. Hammami MM, Siiteri PK. Regulation of 11 beta-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action. J Clin Endocrinol Metab. 1991 ; 73: 326-334 (Pubitemid 21921877)
10. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006 ; 54: 1-15
11. Ito N, Ito T, Kromminga A, Bettermann A, Takigawa M, Kees F, et al. Human hair follicles display a functional equivalent of the hypothalamic-pituitary- adrenal axis and synthesize cortisol. FASEB J. 2005 ; 19: 1332-1334 (Pubitemid 41113740)
12. Jackson S, Gilchrist H, Nesbitt LT. Update on the dermatologic use of systemic glucocorticosteroids. Dermatol Ther. 2007 ; 20: 187-205 (Pubitemid 350029309)
13. Lanza A, Cirillo N, Rossiello R, Rienzo M, Cutillo L, Casamassimi A, et al. Evidence of key role of Cdk2 overexpression in pemphigus vulgaris. J Biol Chem. 2008 ; 283: 8736-8745
14. Lanza A, Stellavato A, Heulfe I, Landi C, Gombos F, Cirillo N. Serum of patients with oral pemphigus vulgaris impairs keratinocyte wound repair in vitro: a time-lapse study on the efficacy of methylprednisolone and pyridostigmine bromide. Oral Dis. 2009 ; 15: 478-483
15. Lim KP, Cirillo N, Hassona Y, Wei W, Thurlow JK, Cheong SC, et al. Fibroblast gene expression profile reflects the stage of tumour progression in oral squamous cell carcinoma. J Pathol. 2011 ; 223: 459-469
16. Nguyen VT, Arredondo J, Chernyavsky AI, Kitajima Y, Pittelkow M, Grando SA. Pemphigus vulgaris IgG and methylprednisolone exhibit reciprocal effects on keratinocytes. J Biol Chem. 2004 ; 279: 2135-2146 (Pubitemid 38084487)
17. Popovsky JL, Camisa C. New and emerging therapies for diseases of the oral cavity. Dermatol Clin. 2000 ; 18: 113-125 (Pubitemid 30013732)
18. Rabbitt EH, Gittoes NJ, Stewart PM, Hewison M. 11beta-hydroxysteroid dehydrogenases, cell proliferation and malignancy. J Steroid Biochem Mol Biol. 2003 ; 85: 415-421 (Pubitemid 37020891)
19. Ricketts ML, Verhaeg JM, Bujalska I, Howie AJ, Rainey WE, Stewart PM. Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues. J Clin Endocrinol Metab. 1998 ; 83: 1325-1335 (Pubitemid 28496416)
20. Sidler D, Renzulli P, Schnoz C, Berger B, Schneider-Jakob S, Flück C, et al. Colon cancer cells produce immunoregulatory glucocorticoids. Oncogene. 2011 ; 30: 2411-2419
21. Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr Rev. 2000 ; 21: 457-487
22. Slominski A, Wortsman J, Foecking MF, Shackleton C, Gomez-Sanchez C, Szczesniewski A. Gas chromatography/mass spectrometry characterization of corticosteroid metabolism in human immortalized keratinocytes. J Invest Dermatol. 2002 ; 118: 310-315 (Pubitemid 34158486)
23. Slominski A, Zbytek B, Szczesniewski A, Semak I, Kaminski J, Sweatman T, et al. CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am J Physiol Endocrinol Metab. 2004 ; 288: E701 - E706
24. Slominski A, Wortsman J, Tuckey RC, Paus R. Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol. 2007 ;: 265-266
25. Smith EW. Do we need new and different glucocorticoids? A re-appraisal of the various congeners and potential alternatives. Curr Probl Dermatol. 1993 ; 21: 1-10
26. Staab CA, Maser E. 11beta-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammation. J Steroid Biochem Mol Biol. 2010 ; 119: 56-72
27. Swanson DL, Dahl MV. Methylprednisolone inhibits pemphigus acantholysis in skin cultures. J Invest Dermatol. 1983 ; 81: 258-260 (Pubitemid 13045265)
28. Temkin S, Nacharaju VL, Hellman M, Lee YC, Abulafia O. Type 2 11beta-hydroxysteroid dehydrogenase activity in human ovarian cancer. Steroids. 2006 ; 71: 1019-1023 (Pubitemid 44573304)
29. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, et al. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev. 2004 ; 25: 831-866 (Pubitemid 39366049)
30. Vukelic S, Stojadinovic O, Pastar I, Rabach M, Krzyzanowska A, Lebrun E, et al. Cortisol synthesis in epidermis is induced by IL-1 and tissue injury. J Biol Chem. 2011 ; 286: 10265-10275
31. Yao ES, Zhang H, Chen YY, Lee B, Chew K, Moore D, et al. Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res. 2007 ; 67: 659-664 (Pubitemid 46192205)
32. Zhang MZ, Xu J, Yao B, Yin H, Cai Q, Shrubsole MJ, et al. Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans. J Clin Invest. 2009 ; 119: 876-885